SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

CORRESP Filing

International Seaways, Inc.
Date: July 31, 2025 · CIK: 0001679049 · Accession: 0001104659-25-072693

Financial Reporting Internal Controls Regulatory Compliance

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 001-37836

Referenced dates: July 16, 2025

Date
July 31, 2025
Author
III
Form
CORRESP
Company
International Seaways, Inc.

Letter

Division of Corporation Finance Office of Energy and Transportation Attention: Ms. Yong Kim Re: International Seaways, Inc. Form 10-K for the Fiscal Year Ended December 31, Filed February 27, 2025 File No. 001-37836

Dear Ms. Kim and Mr. Hiller:

We have reviewed your letter dated July 16, 2025 (the " Comment Letter ") to Jeffrey D. Pribor, Senior Vice President and Chief Financial Officer of International Seaways, Inc. (" INSW " or the " Company ") setting forth the comments of the staff (the " Staff ") of the Division of Corporation Finance of the Securities and Exchange Commission (the " Commission ") on certain disclosures made in INSW's Annual Report on Form 10-K for the year ended December 31, 2024 (the " 2024 Form 10-K "). Set forth below are the Company's responses to the comments contained in the Comment Letter. The Staff's comments, reproduced in bold text, are followed by responses on behalf of the Company. The responses to the Staff's comments are provided in the order in which the comments were set out in your letter and are numbered correspondingly. Based on our review, we respond as follows:

SEC Comment

Financial Statements

General, page 68

1. We note that while you report outstanding common shares within the Balance Sheets on page 69, and weighted average shares utilized in the basic and diluted EPS computations within the Statements of Operations on page 70, you have not reported share activity along with the corresponding financial activity in the Statements of Changes in Equity on page 73, nor provided disclosures that are sufficiently focused on the changes impacting outstanding share balances in Note 12.

Ms. Kim and Mr. Hiller

July 31, 2025

Page 2

We also note that a reconciliation of the denominators utilized in the EPS computations has not been provided in Note 3 on page 80, and although the numbers of dilutive instruments are quantified, the composition is not readily apparent as would ordinarily be shown following the example in FASB ASC 260-10-55-51.

Please revise your financial statements to clearly disclose the changes impacting the number of shares of outstanding equity securities and to include reconciliations of the denominators utilized in the EPS computations to comply with FASB ASC 505-1050-2 and FASB ASC 260-10-50-1. Please also discuss the reasons that your weighted average outstanding shares measures for 2024 exceed the number of outstanding shares at both the start and end of the period.

INSW Response

The Company acknowledges the Staff's comments and will revise going forward the manner in which it discloses the changes impacting the number of shares of outstanding equity securities and the reconciliation of the denominators utilized in the EPS computations in the notes to its financial statements in future quarterly and annual filings, commencing with the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, by:

(a) Expanding the capital stock and stock compensation disclosures with a tabular presentation of the changes in shares of the Company's common stock for all periods reported in the financial statements. If such tabular presentation had been included in the 2024 Form 10-K it would have appeared as follows:

The following table shows the changes in shares of common stock for 2024, 2023 and 2022:

Common stock outstanding, beginning balances 48,925,562 49,120,648 49,612,019

Common stock issued - vessel acquisitions 623,778 - -

Restricted common stock issued - non-executive directors 21,818 26,878 41,718

Common stock issued - vesting or exercise of share-based compensation 283,537 291,813 668,687

Common stock withheld for employee taxes (158,591 ) (147,294 ) (513,479 )

Restricted common stock forfeited - - (557 )

Common stock repurchased (501,646 ) (366,483 ) (687,740 )

Common stock outstanding, ending balances 49,194,458 48,925,562 49,120,648

(b) Expanding the earnings per common share disclosures to include a tabular reconciliation of the denominators utilized in the EPS computations for all periods reported in the financial statements. If such tabular reconciliation had been included in the 2024 Form 10-K it would have appeared as follows:

Ms. Kim and Mr. Hiller

July 31, 2025

Page 3

The components of the denominator for the calculation of basic and diluted net income per share are as follows:

Years Ended December 31,

Weighted-average common shares outstanding, basic 49,270,496 48,978,452 49,381,459

Dilutive effect of stock options 105,835 121,545 122,599

Dilutive effect of performance-based restricted stock units 173,858 127,623 142,708

Dilutive effect of restricted stock units 129,938 201,347 198,138

Weighted-average common shares outstanding, diluted 49,680,127 49,428,967 49,844,904

Regarding the Staff's request for an explanation of the reasons that the Company's weighted average outstanding shares measures for 2024 exceed the number of outstanding shares at both the start and end of the period, please note the following:

a) As noted in Note 5 on page 86, during the second quarter of 2024, the Company issued a total of 623,778 shares in conjunction with vessel acquisitions, such issuances resulted in an outstanding share balance which exceeded the balance at the start of 2024.

b) Subsequently, the total shares repurchased during 2024, which were 501,646 as noted in Note 12 on page 101, took place in the third quarter of 2024. Such repurchases had the effect of decreasing the balance at the end of 2024 below the weighted average outstanding shares for the 2024 annual period.

Ms. Kim and Mr. Hiller

July 31, 2025

Page 4

SEC Comment

Note 12 – Capital Stock and Stock Compensation, page 100

2. We note that you provide a table on page 104 that is prefaced with language indicating it reflects activity in both restricted common shares and restricted stock units, although the summations indicate the balances represent nonvested shares. We also note the activity includes grants, adjusted to exclude forfeitures of stock units, which you indicate are related to performance targets or service requirements that were not achieved, and are adjusted to exclude vested awards.

Please modify your disclosures to clarify how this activity relates to the activity in your Statements of Changes in Equity on page 73 that is labeled "Forfeitures of vested restricted stock awards and exercised stock options" and if such activity has been properly identified, to describe the circumstances under which vested awards were forfeited. Please also revise the headers to the tables in this section where necessary to correspond precisely with the type of securities or instruments being measured.

Please disaggregate activity pertaining to different types of securities or instruments that are presently combined in the summary tables, or expand your disclosures to discuss your rationale and views on the utility of the combined presentation.

INSW Response

The Company acknowledges the Staff's comment and will revise its disclosure to caption its table as "Share-based Compensation Awards Outstanding," rather than "Nonvested Shares Outstanding" in future annual filings.

In addition, the Company will revise the line in the Statements of Changes in Equity labeled "Forfeitures of vested restricted stock awards and exercised stock options" to "Common stock withheld related to net share settlement of equity awards," which further identifies the nature of the activity that is included in this line, in future quarterly and annual filings, commencing with the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.

The difference between (i) the estimated value of the common stock withheld from employees for the net share settlement of equity awards as disclosed on page 102 (derived by multiplying the number of shares withheld/repurchased of 158,591, 147,294 and 513,479 by the average costs of $53.42, $44.09 and $41.79 per share, respectively), and (ii) the amounts disclosed in the "Forfeitures of vested restricted stock awards and exercised stock options" lines of the Statements of Changes in Equity on page 73, represents the dollar value of the common shares withheld from employees to cover the exercise cost of their stock options. As the common shares issued at the exercise of the stock options were simultaneously cancelled to cover the exercise cost of said options, the net impact is appropriately zero in the Statements of Changes in Equity.

Ms. Kim and Mr. Hiller

July 31, 2025

Page 5

(Dollars in Thousands)

Common stock withheld related to net share settlement of equity awards per page 73 $ 7,055 $ 5,819 $ 6,097

Common stock withheld related to net share settlement of equity awards per page 102 8,472 6,494 21,459

$ (1,417 ) $ (675 ) $ (15,362 )

The Company will also disaggregate activity pertaining to the different types of share-based compensation awards in future annual reports commencing with the Company's Annual Report on Form 10-K for the year ended December 31, 2025, as follows:

Activity for the three years ended December 31, Total Restricted Common Stock Time-based Restricted Stock Units Performance-based Restricted Stock Units Stock Options

Share-based Compensation Awards Outstanding at December 31, 2021 1,147,947 87,721 125,119 123,201 811,906

Grants 515,154 41,718 348,846 124,590 -

PRSU Adjustments for above target achievement 16,092 - - 16,092 -

PRSU Cancellations for below target achievement - - - - -

Forfeitures - - - - -

Stock options exercised (1) (541,656 ) - - - (541,656 )

Restricted shares, RSUs and PRSUs Vested ($16.6 - $23.53 per share) (1) (216,889 ) (80,138 ) (62,401 ) (74,350 ) -

Share-based Compensation Awards Outstanding at December 31, 2022 920,648 49,301 411,564 189,533 270,250

Grants 132,658 26,878 52,890 52,890 -

PRSU Adjustments for above target achievement 16,233 - - 16,233 -

PRSU Cancellations for below target achievement (3,641 ) - - (3,641 ) -

Forfeitures - - - - -

Stock options exercised (1) (30,654 ) - - - (30,654 )

Restricted Shares, RSUs and PRSUs Vested ($19.63 - $43.05 per share) (1) (311,004 ) (46,660 ) (186,809 ) (77,535 ) -

Share-based Compensation Awards Outstanding at December 31, 2023 724,240 29,519 277,645 177,480 239,596

Grants 151,974 21,818 82,076 48,080 -

PRSU Adjustments for above target achievement 31,144 - - 31,144 -

PRSU Cancellations for below target achievement - - - - -

Forfeitures - - - - -

Stock options exercised (1) (65,179 ) - - - (65,179 )

Restricted Shares, RSUs and PRSUs Vested ($19.63 - $57.17 per share) (1) (330,186 ) (33,629 ) (140,823 ) (155,734 ) -

Share-based Compensation Awards Outstanding at December 31, 2024 511,993 17,708 218,898 100,970 174,417

(1) Includes 158,591 (2024), 147,294 (2023), and 513,479 (2022) shares of common stock withheld to cover employee withholding taxes and the cost of options exercised in connection with the net settlement of restricted stock units and the exercise of stock options.

Ms. Kim and Mr. Hiller

July 31, 2025

Page 6

The following is a reconciliation of the total of the stock options exercised and RSUs and PRSUs vested lines in the table above to the Common stock issued - vesting or exercise of share-based compensation line in the roll forward of outstanding shares on page 2 of this letter:

Stock options exercised and RSU and PRSUs Vested 395,365 341,658 758,545

Restricted Shares vested (33,629 ) (46,660 ) (80,138 )

PRSUs vested but not issued until following year (155,734 ) (77,535 ) (74,350 )

PRSUs vested in prior year, issued in current year 77,535 74,350 64,630

Common stock issued - vesting or exercise of share-based compensation 283,537 291,813 668,687

* * *

If you have any questions concerning the matters discussed in this letter, please feel free to contact me.

Very truly yours,
s/ JAMES D. SMALL
III

Show Raw Text
CORRESP
 1
 filename1.htm

 600 Third Avenue
 39th Floor
 New York, NY 10016
 USA
 Tel:
 Fax:

 E-mail:
 +1 212-251-1199 +1 212-251-1180

 jsmall@intlseas.com
 James D. Small III
Chief Administrative Officer,
 Senior Vice President,
Secretary & General Counsel

 July 31, 2025

 U.S. Securities and Exchange Commission

 Division of Corporation Finance

 Office of Energy and Transportation

 100 F Street, N.E.

 Washington, D.C. 20549

 Attention:
 Ms. Yong
 Kim

 Mr. Karl Hiller

 Re:
 International Seaways, Inc.

 Form 10-K for the Fiscal Year Ended December 31,
 2024

 Filed February 27, 2025

 File No. 001-37836

 Dear Ms. Kim and Mr. Hiller:

 We have reviewed your letter dated July 16,
2025 (the " Comment Letter ") to Jeffrey D. Pribor, Senior Vice President and Chief Financial Officer of International
Seaways, Inc. (" INSW " or the " Company ") setting forth the comments of the staff (the " Staff ")
of the Division of Corporation Finance of the Securities and Exchange Commission (the " Commission ") on certain disclosures
made in INSW's Annual Report on Form 10-K for the year ended December 31, 2024 (the " 2024 Form 10-K ").
Set forth below are the Company's responses to the comments contained in the Comment Letter. The Staff's comments, reproduced
in bold text, are followed by responses on behalf of the Company. The responses to the Staff's comments are provided in the order
in which the comments were set out in your letter and are numbered correspondingly. Based on our review, we respond as follows:

 SEC Comment

 Financial Statements

 General, page 68

 1. We note that while you report outstanding common shares
 within the Balance Sheets on page 69, and weighted average shares utilized in the basic
 and diluted EPS computations within the Statements of Operations on page 70, you
 have not reported share activity along with the corresponding financial activity in the Statements
 of Changes in Equity on page 73, nor provided disclosures that are sufficiently focused
 on the changes impacting outstanding share balances in Note 12.

 Ms. Kim and Mr. Hiller

 July 31, 2025

 Page 2

 We also note that a reconciliation of the denominators
utilized in the EPS computations has not been provided in Note 3 on page 80, and although the numbers of dilutive instruments
are quantified, the composition is not readily apparent as would ordinarily be shown following the example in FASB ASC 260-10-55-51.

 Please revise your financial statements to clearly
disclose the changes impacting the number of shares of outstanding equity securities and to include reconciliations of the denominators
utilized in the EPS computations to comply with FASB ASC 505-1050-2 and FASB ASC 260-10-50-1. Please also discuss the
reasons that your weighted average outstanding shares measures for 2024 exceed the number of outstanding shares at both the
start and end of the period.

 INSW Response

 The Company acknowledges the Staff's comments and will revise
going forward the manner in which it discloses the changes impacting the number of shares of outstanding equity securities and the reconciliation
of the denominators utilized in the EPS computations in the notes to its financial statements in future quarterly and annual filings,
commencing with the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, by:

 (a) Expanding the capital stock and stock compensation disclosures with a
 tabular presentation of the changes in shares of the Company's common stock for all
 periods reported in the financial statements. If such tabular presentation had been included
 in the 2024 Form 10-K it would have appeared as follows:

 The following table shows the changes in shares of common stock for
2024, 2023 and 2022:

 2024
 2023
 2022

 Common stock outstanding,
 beginning balances
 48,925,562
 49,120,648
 49,612,019

 Common
 stock issued - vessel acquisitions
 623,778
 -
 -

 Restricted
 common stock issued - non-executive directors
 21,818
 26,878
 41,718

 Common
 stock issued - vesting or exercise of share-based compensation
 283,537
 291,813
 668,687

 Common
 stock withheld for employee taxes
 (158,591 )
 (147,294 )
 (513,479 )

 Restricted
 common stock forfeited
 -
 -
 (557 )

 Common
 stock repurchased
 (501,646 )
 (366,483 )
 (687,740 )

 Common stock outstanding, ending
 balances
 49,194,458
 48,925,562
 49,120,648

 (b) Expanding the earnings per common share disclosures to include a tabular
 reconciliation of the denominators utilized in the EPS computations for all periods reported
 in the financial statements. If such tabular reconciliation had been included in the 2024
 Form 10-K it would have appeared as follows:

 Ms. Kim and Mr. Hiller

 July 31, 2025

 Page 3

 The components of the denominator for the calculation of basic and
diluted net income per share are as follows:

 Years
 Ended December 31,

 2024
 2023
 2022

 Weighted-average
 common shares outstanding, basic
 49,270,496
 48,978,452
 49,381,459

 Dilutive effect of stock options
 105,835
 121,545
 122,599

 Dilutive effect of performance-based
 restricted stock units
 173,858
 127,623
 142,708

 Dilutive effect of restricted
 stock units
 129,938
 201,347
 198,138

 Weighted-average common shares
 outstanding, diluted
 49,680,127
 49,428,967
 49,844,904

 Regarding the Staff's request for an explanation of the reasons
that the Company's weighted average outstanding shares measures for 2024 exceed the number of outstanding shares at both
the start and end of the period, please note the following:

 a) As noted in Note 5 on page 86, during the second quarter of
 2024, the Company issued a total of 623,778 shares in conjunction with vessel acquisitions,
 such issuances resulted in an outstanding share balance which exceeded the balance at the
 start of 2024.

 b) Subsequently, the total shares repurchased during 2024, which were
 501,646 as noted in Note 12 on page 101, took place in the third quarter of 2024. Such
 repurchases had the effect of decreasing the balance at the end of 2024 below the weighted
 average outstanding shares for the 2024 annual period.

 Ms. Kim and Mr. Hiller

 July 31, 2025

 Page 4

 SEC Comment

 Note 12 – Capital Stock and Stock Compensation, page 100

 2. We note that you provide a table on page 104
 that is prefaced with language indicating it reflects activity in both restricted common
 shares and restricted stock units, although the summations indicate the balances represent
 nonvested shares. We also note the activity includes grants, adjusted to exclude forfeitures
 of stock units, which you indicate are related to performance targets or service requirements
 that were not achieved, and are adjusted to exclude vested awards.

 Please modify
 your disclosures to clarify how this activity relates to the activity in your
 Statements of Changes in Equity on page 73 that is labeled "Forfeitures
 of vested restricted stock awards and exercised stock options" and if such activity
 has been properly identified, to describe the circumstances under which vested awards were
 forfeited. Please also revise the headers to the tables in this section where necessary to
 correspond precisely with the type of securities or instruments being measured.

 Please disaggregate
 activity pertaining to different types of securities or instruments that are presently
 combined in the summary tables, or expand your disclosures to discuss your rationale
 and views on the utility of the combined presentation.

 INSW Response

 The Company acknowledges the Staff's comment and will revise
its disclosure to caption its table as "Share-based Compensation Awards Outstanding," rather than "Nonvested Shares
Outstanding" in future annual filings.

 In addition, the Company will revise the line in the Statements of
Changes in Equity labeled "Forfeitures of vested restricted stock awards and exercised stock options" to "Common
stock withheld related to net share settlement of equity awards," which further identifies the nature of the activity that
is included in this line, in future quarterly and annual filings, commencing with the Company's Quarterly Report on Form 10-Q
for the quarter ended June 30, 2025.

 The difference between (i) the estimated value of the common
stock withheld from employees for the net share settlement of equity awards as disclosed on page 102 (derived by multiplying the
number of shares withheld/repurchased of 158,591, 147,294 and 513,479 by the average costs of $53.42, $44.09 and $41.79 per share, respectively),
and (ii) the amounts disclosed in the "Forfeitures of vested restricted stock awards and exercised stock options" lines
of the Statements of Changes in Equity on page 73, represents the dollar value of the common shares withheld from employees
to cover the exercise cost of their stock options. As the common shares issued at the exercise of the stock options were simultaneously
cancelled to cover the exercise cost of said options, the net impact is appropriately zero in the Statements of Changes in Equity.

 Ms. Kim and Mr. Hiller

 July 31, 2025

 Page 5

 (Dollars
 in Thousands)

 2024
 2023
 2022

 Common stock withheld related to net share settlement
 of equity awards per page 73
 $ 7,055
 $ 5,819
 $ 6,097

 Common stock withheld related to net
 share settlement of equity awards per page 102
 8,472
 6,494
 21,459

 $ (1,417 )
 $ (675 )
 $ (15,362 )

 The Company will also disaggregate activity pertaining to the different
types of share-based compensation awards in future annual reports commencing with the Company's Annual Report on Form 10-K
for the year ended December 31, 2025, as follows:

 Activity for the three years ended December 31,
 2024
 Total
 Restricted Common
 Stock
 Time-based Restricted
 Stock Units
 Performance-based
 Restricted Stock Units
 Stock Options

 Share-based Compensation Awards Outstanding at
 December 31, 2021
 1,147,947
 87,721
 125,119
 123,201
 811,906

 Grants
 515,154
 41,718
 348,846
 124,590
 -

 PRSU Adjustments for above target achievement
 16,092
 -
 -
 16,092
 -

 PRSU Cancellations for below target achievement
 -
 -
 -
 -
 -

 Forfeitures
 -
 -
 -
 -
 -

 Stock
 options exercised (1)
 (541,656 )
 -
 -
 -
 (541,656 )

 Restricted
 shares, RSUs and PRSUs Vested ($16.6 - $23.53 per share) (1)
 (216,889 )
 (80,138 )
 (62,401 )
 (74,350 )
 -

 Share-based Compensation Awards Outstanding
 at December 31, 2022
 920,648
 49,301
 411,564
 189,533
 270,250

 Grants
 132,658
 26,878
 52,890
 52,890
 -

 PRSU Adjustments for above target achievement
 16,233
 -
 -
 16,233
 -

 PRSU Cancellations for below target achievement
 (3,641 )
 -
 -
 (3,641 )
 -

 Forfeitures
 -
 -
 -
 -
 -

 Stock
 options exercised (1)
 (30,654 )
 -
 -
 -
 (30,654 )

 Restricted
 Shares, RSUs and PRSUs Vested ($19.63 - $43.05 per share) (1)
 (311,004 )
 (46,660 )
 (186,809 )
 (77,535 )
 -

 Share-based Compensation Awards Outstanding
 at December 31, 2023
 724,240
 29,519
 277,645
 177,480
 239,596

 Grants
 151,974
 21,818
 82,076
 48,080
 -

 PRSU Adjustments for above target achievement
 31,144
 -
 -
 31,144
 -

 PRSU Cancellations for below target achievement
 -
 -
 -
 -
 -

 Forfeitures
 -
 -
 -
 -
 -

 Stock
 options exercised (1)
 (65,179 )
 -
 -
 -
 (65,179 )

 Restricted
 Shares, RSUs and PRSUs Vested ($19.63 - $57.17 per share) (1)
 (330,186 )
 (33,629 )
 (140,823 )
 (155,734 )
 -

 Share-based Compensation Awards Outstanding
 at December 31, 2024
 511,993
 17,708
 218,898
 100,970
 174,417

 (1) Includes 158,591 (2024), 147,294 (2023), and 513,479 (2022) shares of
 common stock withheld to cover employee withholding taxes and the cost of options exercised
 in connection with the net settlement of restricted stock units and the exercise of stock
 options.

 Ms. Kim and Mr. Hiller

 July 31, 2025

 Page 6

 The following is a reconciliation of the total of the stock options
exercised and RSUs and PRSUs vested lines in the table above to the Common stock issued - vesting or exercise of share-based compensation
line in the roll forward of outstanding shares on page 2 of this letter:

 2024
 2023
 2022

 Stock options exercised
 and RSU and PRSUs Vested
 395,365
 341,658
 758,545

 Restricted Shares vested
 (33,629 )
 (46,660 )
 (80,138 )

 PRSUs
 vested but not issued until following year
 (155,734 )
 (77,535 )
 (74,350 )

 PRSUs
 vested in prior year, issued in current year
 77,535
 74,350
 64,630

 Common stock issued - vesting
 or exercise of share-based compensation
 283,537
 291,813
 668,687

 *	 * 	 *

 If you have any questions concerning the matters
discussed in this letter, please feel free to contact me.

 Very truly yours,

 s/ JAMES D. SMALL
 III

 James D. Small III

 cc: Jeffrey D. Pribor

 Senior Vice President and Chief Financial
Officer, International Seaways

 Lois K. Zabrocky

 President & CEO, International Seaways

 Audit Committee (International Seaways)

 Jeffrey D. Karpf

 Helena K. Grannis

 Cleary Gottlieb Steen & Hamilton LLP